SC 13G/A | 2018-04-10 | PRIMECAP MANAGEMENT CO/CA/ | Bioverativ Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2018-02-27 | PRIMECAP MANAGEMENT CO/CA/ | Bioverativ Inc. | 7,622,324 | 7.1% | EDGAR |
SC 13G/A | 2018-02-14 | HealthCor Management, L.P. | Bioverativ Inc. | 3,750,000 | 3.5% | EDGAR |
SC 13G | 2018-02-08 | VANGUARD GROUP INC | Bioverativ Inc. | 9,226,008 | 8.5% | EDGAR |
SC 13G | 2018-01-09 | BlackRock Inc. | Bioverativ Inc. | 10,845,635 | 10.0% | EDGAR |
SC 13D/A | 2017-07-17 | VA Partners I, LLC | Bioverativ Inc. | 4,079,892 | 3.8% | EDGAR |
SC 13G | 2017-04-13 | HealthCor Management, L.P. | Bioverativ Inc. | 5,500,000 | 5.1% | EDGAR |
SC 13G | 2017-03-06 | PRIMECAP MANAGEMENT CO/CA/ | Bioverativ Inc. | 7,756,374 | 7.2% | EDGAR |
SC 13D/A | 2017-03-02 | VA Partners I, LLC | Bioverativ Inc. | 8,132,880 | 7.5% | EDGAR |
SC 13D | 2017-02-17 | VA Partners I, LLC | Bioverativ Inc. | 7,700,000 | 7.1% | EDGAR |